Mingxin Che
Impact in
- Physiology top 2%
- Adenosine and Purinergic Signaling
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Protease and Inhibitor Mechanisms
Papers in
- Oncology 11
- Drug Transport and Resistance Mechanisms 3
-
- Prostate Cancer Treatment and Research 5
- Renal cell carcinoma treatment 3
- Co-authors
- David J. Grignon (12 shared papers)Irwin M. Arias (5 shared papers)Fazlul H. Sarkar (7 shared papers)Daniel Ortiz (1 shared paper)Zenaida Gatmaitan (4 shared papers)Judith Abrams (5 shared papers)Ömer Küçük (5 shared papers)Michael L. Cher (4 shared papers)
- Journals
- Hepatology (3 papers)Cancer Research (3 papers)Cancer (2 papers)Pathology International (2 papers)Cancer and Metastasis Reviews (2 papers)
- Partner nations
- United StatesIndiaSouth Korea
In The Last Decade
Mingxin Che
38 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 99
- Physiology 152
- Cancer Research 375
- Oncology 535
- Biochemistry 120
- Pathology and Forensic Medicine 220
Countries citing papers authored by Mingxin Che
This map shows the geographic impact of Mingxin Che's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxin Che with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxin Che more than expected).
Fields of papers citing papers by Mingxin Che
This network shows the impact of papers produced by Mingxin Che. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxin Che. The network helps show where Mingxin Che may publish in the future.
Co-authors
The 25 scholars most cited alongside Mingxin Che, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1995 | 148 | |
| 2 | 2003 | 133 | |
| 3 | 1993 | 130 | |
| 4 | 2004 | 106 | |
| 5 | 2005 | 97 | |
| 6 | 2004 | 93 | |
| 7 | 2001 | 93 | |
| 8 | 2005 | 91 | |
| 9 | 2010 | 90 | |
| 10 | 2002 | 84 | |
| 11 | 2009 | 78 | |
| 12 | 2007 | 78 | |
| 13 | 2004 | 77 | |
| 14 | 2007 | 75 | |
| 15 | 2005 | 71 | |
| 16 | 2003 | 67 | |
| 17 | 2008 | 55 | |
| 18 | 2007 | 48 | |
| 19 | 1997 | 44 | |
| 20 | 2006 | 43 |
About Mingxin Che
Mingxin Che is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Pharmacology, having authored 38 papers that have together received 2.0k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (8 papers), Cancer, Lipids, and Metabolism (5 papers), Prostate Cancer Treatment and Research (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Phytoestrogen effects and research (4 papers), Renal cell carcinoma treatment (3 papers), Drug Transport and Resistance Mechanisms (3 papers) and Renal and related cancers (3 papers). The work is most often cited by research in Physiology (152 citations), Cancer Research (375 citations), Oncology (535 citations), Biochemistry (120 citations) and Pathology and Forensic Medicine (220 citations). Mingxin Che has collaborated with scholars based in United States, India and South Korea. Frequent co-authors include David J. Grignon, Irwin M. Arias, Fazlul H. Sarkar, Daniel Ortiz, Zenaida Gatmaitan, Judith Abrams, Ömer Küçük, Michael L. Cher, Daniel R. Doerge and Gilda G. Hillman. Their work appears in journals such as Hepatology, Cancer Research, Cancer, Pathology International and Cancer and Metastasis Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.